Atrium Innovations Incorporation - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Atrium Innovations Incorporation Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

Atrium Innovations Incorporation Formerly known as Atrium Biotechnologies Inc. The Group's principal activities are to develop, manufacture and market value-added products for the cosmetics, pharmaceutical, chemical and nutrition industries. During the year the Group discontinued the Active Ingredients and Specialty Chemical Division and now operates under one segment, the Health and Nutrition Division. The Group sells and markets its products in more than 35 countries, primarily in North America, Europe and Asia. On 02-Jan-2009, the Group acquired EAB Enzym-Arzneimittel-Berlin GmbH.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report